Literature DB >> 11096750

Orthostatic Hypotension in Multiple System Atrophy.

.   

Abstract

There is no known way to cure multiple system atrophy or even to slow its insidious progression, but there are opportunities to treat many of its symptoms and complications. Of all the autonomic disturbances it causes, orthostatic hypotension is associated with one of the better chances for successful intervention. Milder symptoms may be treated by nonpharmacologic means (eg, changes in diet and activities and compressive maneuvers and devices). Syncopal patients will require treatment with medications. Midodrine is the most effective drug. It is more physiologic and better tolerated, but much more expensive, than fludrocortisone. The latter is often beneficial but frequently causes lower limb edema. Low-dose propranolol is occasionally useful. Other drugs worth trying are indomethacin and intranasal desmopressin. The variety of measures available to treat orthostatic hypotension in multiple system atrophy affords physicians some prospect of easing the suffering of many patients with this otherwise disabling and discouraging disorder.

Entities:  

Year:  2000        PMID: 11096750     DOI: 10.1007/s11940-000-0005-2

Source DB:  PubMed          Journal:  Curr Treat Options Neurol        ISSN: 1092-8480            Impact factor:   3.598


  22 in total

1.  A neurological syndrome associated with orthostatic hypotension: a clinical-pathologic study.

Authors:  G M SHY; G A DRAGER
Journal:  Arch Neurol       Date:  1960-05

2.  Octreotide in the management of orthostatic hypotension in multiple system atrophy: pilot trial of chronic administration.

Authors:  R Bordet; J Benhadjali; C Libersa; A Destée
Journal:  Clin Neuropharmacol       Date:  1994-08       Impact factor: 1.592

Review 3.  Treatment of postural hypotension.

Authors:  C J Mathias; J R Kimber
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-09       Impact factor: 10.154

4.  Could treatment with DOPS do for autonomic failure what DOPA did for Parkinson's disease?

Authors:  H Kaufmann
Journal:  Neurology       Date:  1996-12       Impact factor: 9.910

5.  Orthostatic hypotension and nicotine sensitivity in a case of multiple system atrophy.

Authors:  J G Graham; D R Oppenheimer
Journal:  J Neurol Neurosurg Psychiatry       Date:  1969-02       Impact factor: 10.154

6.  The combination of hypointense and hyperintense signal changes on T2-weighted magnetic resonance imaging sequences: a specific marker of multiple system atrophy?

Authors:  E Kraft; J Schwarz; C Trenkwalder; T Vogl; T Pfluger; W H Oertel
Journal:  Arch Neurol       Date:  1999-02

7.  Physical manoeuvres for combating orthostatic dizziness in autonomic failure.

Authors:  J J van Lieshout; A D ten Harkel; W Wieling
Journal:  Lancet       Date:  1992-04-11       Impact factor: 79.321

8.  Role of physical countermaneuvers in the management of orthostatic hypotension: efficacy and biofeedback augmentation.

Authors:  C M Bouvette; B R McPhee; T L Opfer-Gehrking; P A Low
Journal:  Mayo Clin Proc       Date:  1996-09       Impact factor: 7.616

9.  Treatment of idiopathic orthostatic hypotension (Shy-Drager syndrome) with indomethacin.

Authors:  M S Kochar; H D Itskovitz
Journal:  Lancet       Date:  1978-05-13       Impact factor: 79.321

10.  A double-blind, dose-response study of midodrine in neurogenic orthostatic hypotension.

Authors:  R A Wright; H C Kaufmann; R Perera; T L Opfer-Gehrking; M A McElligott; K N Sheng; P A Low
Journal:  Neurology       Date:  1998-07       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.